• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Cytosorbents Corp

+ Add to Watchlist


0.170 EUR 0.010 6.25%

As of 02:13:44 ET on 09/22/2014.

Snapshot for Cytosorbents Corp (HQE)

Open: 0.170 Day's Range: 0.170 - 0.170 Volume: 0
Previous Close: 0.160 52wk Range: 0.057 - 0.266 1-Yr Rtn: +132.88%

Stock Chart for HQE

No chart data available.
  • HQE:GR 0.170
  • 1M
  • 1Y
Interactive HQE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HQE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.0330
Est. PEG Ratio -
Market Cap (M EUR) 52.82
Shares Outstanding (M) 310.70
30 Day Average Volume 1,158
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HQE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HQE

Cytosorbents Corp. is involved in the research, development and commercialization of medical devices with its platform blood purification technology. The Company focuses on developing this technology for multiple applications in the medical field for the treatment of acute and chronic health complications associated with blood toxicity.

Phillip ChanPresident/CEOKathleen P Bloch "Kathy"Chief Financial Officer
Vincent CapponiChief Operating OfficerRobert BartlettChief Medical Officer
More Company Profile & Key Executives for HQE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil